Literature DB >> 17351078

The pathogenic fungus Cryptococcus neoformans expresses two functional GDP-mannose transporters with distinct expression patterns and roles in capsule synthesis.

Tricia R Cottrell1, Cara L Griffith, Hong Liu, Ashley A Nenninger, Tamara L Doering.   

Abstract

Cryptococcus neoformans is a fungal pathogen that is responsible for life-threatening disease, particularly in the context of compromised immunity. This organism makes extensive use of mannose in constructing its cell wall, glycoproteins, and glycolipids. Mannose also comprises up to two-thirds of the main cryptococcal virulence factor, a polysaccharide capsule that surrounds the cell. The glycosyltransfer reactions that generate cellular carbohydrate structures usually require activated donors such as nucleotide sugars. GDP-mannose, the mannose donor, is produced in the cytosol by the sequential actions of phosphomannose isomerase, phosphomannomutase, and GDP-mannose pyrophosphorylase. However, most mannose-containing glycoconjugates are synthesized within intracellular organelles. This topological separation necessitates a specific transport mechanism to move this key precursor across biological membranes to the appropriate site for biosynthetic reactions. We have discovered two GDP-mannose transporters in C. neoformans, in contrast to the single such protein reported previously for other fungi. Biochemical studies of each protein expressed in Saccharomyces cerevisiae show that both are functional, with similar kinetics and substrate specificities. Microarray experiments indicate that the two proteins Gmt1 and Gmt2 are transcribed with distinct patterns of expression in response to variations in growth conditions. Additionally, deletion of the GMT1 gene yields cells with small capsules and a defect in capsule induction, while deletion of GMT2 does not alter the capsule. We suggest that C. neoformans produces two GDP-mannose transporters to satisfy its enormous need for mannose utilization in glycan synthesis. Furthermore, we propose that the two proteins have distinct biological roles. This is supported by the different expression patterns of GMT1 and GMT2 in response to environmental stimuli and the dissimilar phenotypes that result when each gene is deleted.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17351078      PMCID: PMC1899245          DOI: 10.1128/EC.00015-07

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  61 in total

Review 1.  A yeast under cover: the capsule of Cryptococcus neoformans.

Authors:  Indrani Bose; Amy J Reese; Jeramia J Ory; Guilhem Janbon; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2003-08

2.  Guanosine diphosphate mannose.

Authors:  E CABIB; L F LELOIR
Journal:  J Biol Chem       Date:  1954-02       Impact factor: 5.157

3.  Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence.

Authors:  Amy J Reese; Aki Yoneda; Julia A Breger; Anne Beauvais; Hong Liu; Cara L Griffith; Indrani Bose; Myoung-Ju Kim; Colleen Skau; Sarah Yang; Julianne A Sefko; Masako Osumi; Jean-Paul Latge; Eleftherios Mylonakis; Tamara L Doering
Journal:  Mol Microbiol       Date:  2007-03       Impact factor: 3.501

4.  Molecular characterization of human UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter, a novel nucleotide sugar transporter with dual substrate specificity.

Authors:  M Muraoka; M Kawakita; N Ishida
Journal:  FEBS Lett       Date:  2001-04-20       Impact factor: 4.124

5.  SQV-7, a protein involved in Caenorhabditis elegans epithelial invagination and early embryogenesis, transports UDP-glucuronic acid, UDP-N- acetylgalactosamine, and UDP-galactose.

Authors:  P Berninsone; H Y Hwang; I Zemtseva; H R Horvitz; C B Hirschberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

6.  Identification of a conserved motif in the yeast golgi GDP-mannose transporter required for binding to nucleotide sugar.

Authors:  X D Gao; A Nishikawa; N Dean
Journal:  J Biol Chem       Date:  2000-11-06       Impact factor: 5.157

7.  Improvements to gene deletion in the fungal pathogen Cryptococcus neoformans: absence of Ku proteins increases homologous recombination, and co-transformation of independent DNA molecules allows rapid complementation of deletion phenotypes.

Authors:  Chelsey L Goins; Kimberly J Gerik; Jennifer K Lodge
Journal:  Fungal Genet Biol       Date:  2006-05-22       Impact factor: 3.495

8.  The human solute carrier gene SLC35B4 encodes a bifunctional nucleotide sugar transporter with specificity for UDP-xylose and UDP-N-acetylglucosamine.

Authors:  Angel Ashikov; Françoise Routier; Jutta Fuhlrott; Yvonne Helmus; Martin Wild; Rita Gerardy-Schahn; Hans Bakker
Journal:  J Biol Chem       Date:  2005-05-23       Impact factor: 5.157

9.  Molecular cloning of two Arabidopsis UDP-galactose transporters by complementation of a deficient Chinese hamster ovary cell line.

Authors:  Hans Bakker; Françoise Routier; Stefan Oelmann; Wilco Jordi; Arjen Lommen; Rita Gerardy-Schahn; Dirk Bosch
Journal:  Glycobiology       Date:  2004-09-29       Impact factor: 4.313

10.  The yeast VRG4 gene is required for normal Golgi functions and defines a new family of related genes.

Authors:  J B Poster; N Dean
Journal:  J Biol Chem       Date:  1996-02-16       Impact factor: 5.157

View more
  32 in total

1.  Controlled enlargement of the glycoprotein vesicle surrounding a volvox embryo requires the InvB nucleotide-sugar transporter and is required for normal morphogenesis.

Authors:  Noriko Ueki; Ichiro Nishii
Journal:  Plant Cell       Date:  2009-04-03       Impact factor: 11.277

Review 2.  The role of nucleotide sugar transporters in development of eukaryotes.

Authors:  Li Liu; Yu-Xin Xu; Carlos B Hirschberg
Journal:  Semin Cell Dev Biol       Date:  2010-02-06       Impact factor: 7.727

3.  A xylosylphosphotransferase of Cryptococcus neoformans acts in protein O-glycan synthesis.

Authors:  Morgann C Reilly; Kazuhiro Aoki; Zhuo A Wang; Michael L Skowyra; Matthew Williams; Michael Tiemeyer; Tamara L Doering
Journal:  J Biol Chem       Date:  2011-05-23       Impact factor: 5.157

Review 4.  Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.

Authors:  Kyung J Kwon-Chung; James A Fraser; Tamara L Doering; Zhou Wang; Guilhem Janbon; Alexander Idnurm; Yong-Sun Bahn
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-01       Impact factor: 6.915

5.  Interaction of Cryptococcus neoformans Rim101 and protein kinase A regulates capsule.

Authors:  Teresa R O'Meara; Diana Norton; Michael S Price; Christie Hay; Meredith F Clements; Connie B Nichols; J Andrew Alspaugh
Journal:  PLoS Pathog       Date:  2010-02-19       Impact factor: 6.823

6.  Cryptococcus neoformans UGT1 encodes a UDP-Galactose/UDP-GalNAc transporter.

Authors:  Lucy X Li; Angel Ashikov; Hong Liu; Cara L Griffith; Hans Bakker; Tamara L Doering
Journal:  Glycobiology       Date:  2016-08-03       Impact factor: 4.313

7.  The Drosophila neurally altered carbohydrate mutant has a defective Golgi GDP-fucose transporter.

Authors:  Christoph Geisler; Varshika Kotu; Mary Sharrow; Dubravko Rendić; Gerald Pöltl; Michael Tiemeyer; Iain B H Wilson; Donald L Jarvis
Journal:  J Biol Chem       Date:  2012-06-28       Impact factor: 5.157

Review 8.  How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans.

Authors:  Tamara Lea Doering
Journal:  Annu Rev Microbiol       Date:  2009       Impact factor: 15.500

9.  Cryptococcus neoformans dual GDP-mannose transporters and their role in biology and virulence.

Authors:  Zhuo A Wang; Cara L Griffith; Michael L Skowyra; Nichole Salinas; Matthew Williams; Ezekiel J Maier; Stacey R Gish; Hong Liu; Michael R Brent; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2014-04-18

Review 10.  The capsule of the fungal pathogen Cryptococcus neoformans.

Authors:  Oscar Zaragoza; Marcio L Rodrigues; Magdia De Jesus; Susana Frases; Ekaterina Dadachova; Arturo Casadevall
Journal:  Adv Appl Microbiol       Date:  2009       Impact factor: 5.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.